NASDAQ

Arbutus Biopharma Corporation (ABUS)

♥ 489 Thanks from members

Live price chart, market sentiment, and community perspectives for Arbutus Biopharma Corporation (NASDAQ: ABUS).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Arbutus Biopharma ScientistsLeadership: Michael J. McElhaugh (Interim CEO)Leadership: Gaston Picchio (CSO)Holder: Roivant SciencesHolder: The Vanguard GroupHolder: BlackRock, Inc.AB-729RNA Interference TherapeuticsLNP Delivery Technologies#ABUS stock#Arbutus Biopharma#hepatitis B cure#NASDAQ ABUS#RNAi therapeutics